Germline BRCA mutation and outcome in young-onset breast cancer (POSH): a prospective cohort study.There was no significant difference in overall survival between BRCA-positive and BRCA-negative patients in multivariable analyses at any timepoint 2-10 years. User Garrison_Forrdd, in the Reddit Science subreddit, 20 Jan 2018